ANEB
Anebulo Pharmaceuticals, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website anebulo.com
- Employees(FY) 2
- ISIN US0345691036
Performance
-23.34%
1W
-22.3%
1M
-19.3%
3M
+9.0%
6M
-4.96%
YTD
-0.87%
1Y
Profile
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. The company's lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is based in Lakeway, Texas.
Technical Analysis of ANEB 2024-05-10
Overview:
In analyzing the technical indicators for ANEB over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for potential invest...
Recent News & Updates
- 2024-05-15 09:55
- 2024-05-15 01:05
- 2024-02-13 03:05
- 2023-11-14 03:05
- 2023-10-18 21:40
- 2023-10-06 04:06
- 2023-10-06 04:06
Anebulo Pharmaceuticals Announces New CEO(Businesswire)
- 2023-10-02 21:40
Are Medical Stocks Lagging Exact Sciences (EXAS) This Year?(Yahoo Finance)
- 2023-09-20 22:06
- 2023-09-20 04:29
- 2023-08-29 20:00
- 2023-08-21 21:37
Anebulo (ANEB) Gains on Positive FDA Response for ANEB-001(Yahoo Finance)
- 2023-08-20 20:00
- 2023-08-14 22:20
Sidoti Events, LLCs Virtual August Micro-Cap Conference(Yahoo Finance)
- 2023-06-11 21:40
- 2023-05-29 20:33
- 2023-05-23 21:40
- 2023-05-18 21:35
- 2023-05-10 20:00
- 2023-03-27 20:00
- 2023-03-07 19:00
- 2023-02-13 20:30
- 2023-02-09 19:38
- 2023-01-08 19:00
- 2022-12-20 16:42
- 2022-11-09 19:00
- 2022-11-01 04:00
- 2022-09-25 20:56
- 2022-09-25 19:00
- 2022-09-25 19:00
Page 1 of 3
previousnext